Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
15.62
-0.30 (-1.88%)
At close: Apr 28, 2026, 4:00 PM EDT
15.62
0.00 (0.00%)
Pre-market: Apr 29, 2026, 4:20 AM EDT
Corvus Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,312 | 575 | 344 | 86 | 40 | 112 | |
| Market Cap Growth | 546.29% | 67.27% | 298.31% | 118.11% | -64.73% | 12.29% | |
| Enterprise Value | 1,256 | 510 | 302 | 56 | -7 | 40 | |
| Last Close Price | 15.62 | 7.70 | 5.35 | 1.76 | 0.85 | 2.41 | |
| PB Ratio | 19.06 | 9.40 | 10.56 | 2.23 | 0.71 | 1.16 | |
| P/TBV Ratio | 21.44 | 9.40 | 10.56 | 2.23 | 0.71 | 1.16 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.04 | 0.05 | 0.04 | |
| Net Debt / Equity Ratio | -0.91 | -0.91 | -1.56 | -0.67 | -0.71 | -0.68 | |
| Net Debt / EBITDA Ratio | 1.30 | 1.30 | 1.85 | 1.11 | 1.26 | 1.74 | |
| Net Debt / FCF Ratio | 1.69 | 1.69 | 2.00 | 1.08 | 1.46 | 1.79 | |
| Quick Ratio | 6.09 | 6.09 | 1.47 | 3.96 | 3.99 | 7.22 | |
| Current Ratio | 6.21 | 6.21 | 1.54 | 4.07 | 4.06 | 7.36 | |
| Return on Equity (ROE) | -32.60% | -32.60% | -174.85% | -57.02% | -53.90% | -51.08% | |
| Return on Assets (ROA) | -38.36% | -38.36% | -30.09% | -25.63% | -22.50% | -24.61% | |
| Return on Capital Employed (ROCE) | -69.60% | -69.60% | -82.20% | -60.30% | -55.60% | -38.50% | |
| Earnings Yield | -1.16% | -2.66% | -18.12% | -31.32% | -104.39% | -38.55% | |
| FCF Yield | -2.51% | -5.73% | -7.40% | -27.77% | -68.97% | -32.73% | |
| Buyback Yield / Dilution | -30.76% | -30.76% | -26.99% | -3.16% | -11.23% | -41.98% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.